Amer Zeidan: Big data and quality of life measures to improve outcomes of MDS patients in iwMDS24 with talks from Spain

Amer Zeidan shared on X:

“Mikkael A. Sekeres and Hetty Carraway moderating a great session about use of big data and quality of life measures to improve outcomes of MDS patients in iwMDS24 with talks from Spain (Dr Orgueria), Japan (Dr Miyazaki), Italy (Dr Efficace) and (Dr Sekeres). ”

Source: Amer Zeidan/X

Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center.

Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.